financetom
Business
financetom
/
Business
/
Masco's Q4 Adjusted Earnings Increase, Net Sales Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masco's Q4 Adjusted Earnings Increase, Net Sales Decline
Feb 11, 2025 5:01 AM

07:28 AM EST, 02/11/2025 (MT Newswires) -- Masco ( MAS ) reported Q4 adjusted earnings Tuesday of $0.89 per share, up from $0.83 a year earlier.

Analysts polled by FactSet expected $0.88.

Net sales for the quarter ended Dec. 31 were $1.83 billion, compared with $1.88 billion a year earlier.

Analysts polled by FactSet expected $1.84 billion.

The company said it expects 2025 adjusted EPS of $4.20 to $4.45. Analysts polled by FactSet expect $4.40.

Masco ( MAS ) also said its board approved a 7% increase in quarterly dividend to $0.31 per share, payable on March 10 to shareholders as of Feb. 21.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cantaloupe to Be Acquired by 365 Retail Markets
Cantaloupe to Be Acquired by 365 Retail Markets
Jun 16, 2025
09:39 AM EDT, 06/16/2025 (MT Newswires) -- Cantaloupe (CTLP) said Monday it has agreed to be acquired by 365 Retail Markets in an all-cash deal with an equity value of about $848 million. Under the terms of the deal, Cantaloupe said its shareholders will get $11.20 per share in cash from 365, a portfolio company owned by private equity firm...
AbbVie Says Myelodysplastic Syndrome Phase 3 Trial Failed to Meet Primary Endpoint
AbbVie Says Myelodysplastic Syndrome Phase 3 Trial Failed to Meet Primary Endpoint
Jun 16, 2025
09:37 AM EDT, 06/16/2025 (MT Newswires) -- AbbVie ( ABBV ) said Monday that a global phase 3 trial assessing venetoclax plus azacitidine in treating newly diagnosed higher-risk myelodysplastic syndrome did not meet the primary endpoint for overall survival. The company said there were no observed new safety signals. The company also said that any current approved indications for venetoclax...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Roku Stock Surges On New Integration With Amazon: Details Of The Deal
Roku Stock Surges On New Integration With Amazon: Details Of The Deal
Jun 16, 2025
Roku Inc ( ROKU ) shares are rising Monday after the company announced a new strategic integration with Amazon Ads. What To Know: Roku ( ROKU ) entered into a new exclusive partnership with Amazon.com Inc ( AMZN ) Ads, providing access for advertisers to the largest authenticated Connected TV (CTV) footprint in the U.S. exclusively through Amazon’s demand-side platform...
Copyright 2023-2026 - www.financetom.com All Rights Reserved